SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001906425-22-000001
Filing Date
2022-04-22
Accepted
2022-04-22 16:15:02
Documents
1
Effectiveness Date
2022-04-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12314
  Complete submission text file 0001906425-22-000001.txt   13344
Mailing Address 2614 BOSTON POST ROAD, #33A GUILFORD CT 06437
Business Address 2614 BOSTON POST ROAD, #33A GUILFORD CT 06437 203-204-6363
Invea Therapeutics, Inc (Filer) CIK: 0001906425 (see all company filings)

IRS No.: 873198325 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-443077 | Film No.: 22845681